Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $4.65 | Change: +$0.12 | %Change: +2.65%
Volume: 61,162 | Day High/Low: 4.76/4.45 | 52 Week High/Low: 10.36/2.50
View modes: 
0 stars

RE:RE:Manipulation - Acquisition?

Like most pharmas, Hzmp trades at very high multiples to sales. In Horizon' s case, it trades at 13 times sales. That means that the average contributing drug which includes P2 , trades at 13 times...read more
0 stars

RE:Manipulation - Acquisition?

Without leadership , we will not go anywhere.... this leader has doubled his stock value since Jan .... Horizon Pharma Inc HZNP Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty ...read more
0 stars

Manipulation - Acquisition?

We're approaching 3 months since the stock price was taken down below $5 (after the WF10 announcement on January 30). Many acquisitions are based partially on a 90 day (calendar) weighted average...read more
3 stars

Back to $ 4.00

Shi......With nuvo the glimmer of hope never lasts  rate and reply
5 stars

Ground Hog Day

Once again the "day has reset". What did we learn this time around to carry forward? It is probably an excellent time to buy more shares. There are two distinct events laid out that shareholders can...read more
3 stars

For the WF10 Doubters...PAR were Significant in 2014

Obviously, some of you have not reviewed the 2014 results in detail. These are provided in a new corporate presentation which can be viewed here...http://www.nuvoresearch.com/wp-content/uploads/2015...read more
1 star

World Class Allergy EEC right next door in Missisauga

Inflamax Research to Present Data Demonstrating Validation of Environmental Exposure Chambers for Pivotal Allergy Research at the Paul-Ehrlich Institute in Germany Dr. Anne Marie Salapatek will...read more
1 star

RE:RE:Speculation only, WF 10 has no results yet

Statistically speaking, there was a 1 in a 1000 chance that the 2014 results would turn out any different than those of 2010. Methodoligically speaking, there were any number of potential outcomes in...read more
5 stars

RE:RE:RE:RE:RE:Management hired consultants to help!

No company officials will ever in a million years  disclose some of  items posted on this bull board.  rate and reply
1 star

RE:Speculation only, WF 10 has no results yet

Aversion to speculation is exactly why the spin-off is a good idea. Once the WF-10 branch is its own entity, you can sell those shares while keeping only the shares from the branch committed to...read more
1 star

Speculation only, WF 10 has no results yet

I do not like speculations, there is no proove that WF10 will give the results that we are waiting for.. Stop to say anithing for boosting the share and wait for more news in the next six months.  rate and reply
3 stars

RE:RE:RE:RE:Management hired consultants to help!

Its to your general disadvantage not to talk with management. Afterall, they will discuss issues that you want to raise. This is no different than most other companies. If you have not talked with...read more
5 stars

RE:RE:RE:Management hired consultants to help!

J L told me this and J L told me that , is there a direct  tel. line for every one to use? TIA.  rate and reply
1 star

Lest we forget

Once WF10... In the presumptive case..is approved, say, for a specific allergen ( eg house dust mites ) drug and given its safety profile, physicians and allergic specualists can prescribe it for a...read more
1 star

RE:RE:RE:RE:Management hired consultants to help!

Yes, of course. I was told the same. But, the trials soon to begin will be conducted to confirm or otherwise that WF10 has anti allergic properties. This sets and satisfies the conditions needed for...read more
1 star

RE:RE:RE:Management hired consultants to help!

Typo. Should have read: "However, he made it clear that the FDA or any other regulatory agency would NOT approve WF10 without meeting efficacy endpoints in a field study." Sorry.  rate and reply
1 star

RE:RE:Management hired consultants to help!

John London told me on the phone in February after the WF10 trial failed, that a separate Allergen Chamber arm would be considered in a future WF10 trial. However, he made it clear that the FDA or any...read more
4.5 stars

Spin off questions

I have lots of experience with stock splits and reverse spits to :(, While a lot of posters have again reverted to unbridled optimism, I  am more than a bit skeptical as to how this  unlocking of...read more
5 stars

RE:RE:Nuvo estimated up to $1.1 billion US in sales in US alone

We should see $4.75----- $5.00 tomorrow  rate and reply
3 stars

RE:Nuvo estimated up to $1.1 billion US in sales in US alone

Circassia IPOed one year ago at $400 million. Its top drug , catsphire, had Forecast peak sales of $500 to $700 million in the US. Its 3 years away from commercial sales. WF10 is much more...read more